Skinvisible, Inc.
- Jurisdiction
United States - ISIN
US8307032032 (SKVI )- Sectors
Scores
- Fair value (Benjamin Graham formula)
- N/A
- Financial strength (Piotroski F-Value)
-
4
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
1
/ 7
Profile
Skinvisible, Inc., together with its subsidiaries, focuses on the development, manufacture, and sale of topical, transdermal, and mucosal polymer-based delivery system technologies and formulations for use in pharmaceutical, over the counter, personal skincare, and cosmetic arenas. Read full profile
Fundamentals
- Net revenue
€17.06K - Gross margin
100.0% - EBIT
-€511.60K - EBIT margin
-2,999.0% - Net income
-€449.73K - Net margin
-2,636.3%
Statement period: - (published )
Stock price
Dividends
No dividend payouts
Analyst ratings
No analyst ratings available
Insider Transactions
No insider transactions in the last 90 days. View older insider transactions